Pear Therapeutics, a developer of prescription digital therapies, has gone public through a merger with Thimble Point Acquisition Corp., a special purpose acquisition company.
Join The Ecosystem
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.